Therapeutic Potential of Marine Peptides in Prostate Cancer: Mechanistic Insights
Open Access
- 22 July 2022
- journal article
- review article
- Published by MDPI AG in Marine Drugs
- Vol. 20 (8) , 466
Abstract
Prostate cancer (PCa) is the leading cause of cancer death in men, and its treatment is commonly associated with severe adverse effects. Thus, new treatment modalities are required. In this context, natural compounds have been widely explored for their anti-PCa properties. Aquatic organisms contain numerous potential medications. Anticancer peptides are less toxic to normal cells and provide an efficacious treatment approach via multiple mechanisms, including altered cell viability, apoptosis, cell migration/invasion, suppression of angiogenesis and microtubule balance disturbances. This review sheds light on marine peptides as efficacious and safe therapeutic agents for PCa.Keywords
This publication has 118 references indexed in Scilit:
- Predictive Factors of Sensitivity to Elisidepsin, a Novel Kahalalide F-Derived Marine CompoundMarine Drugs, 2013
- Synthesis and evaluation of hermitamides A and B as human voltage-gated sodium channel blockersBioorganic & Medicinal Chemistry, 2011
- Depsipeptides from a Guamanian marine cyanobacterium, Lyngbya bouillonii, with selective inhibition of serine proteasesTetrahedron Letters, 2010
- Tiglicamides A–C, cyclodepsipeptides from the marine cyanobacterium Lyngbya confervoidesPhytochemistry, 2009
- Palmyramide A, a Cyclic Depsipeptide from a Palmyra Atoll Collection of the Marine CyanobacteriumLyngbya majusculaJournal of Natural Products, 2009
- Grassystatins A−C from Marine Cyanobacteria, Potent Cathepsin E Inhibitors That Reduce Antigen PresentationJournal of Medicinal Chemistry, 2009
- The p53 family and programmed cell deathOncogene, 2008
- Coibamide A, a Potent Antiproliferative Cyclic Depsipeptide from the Panamanian Marine Cyanobacterium Leptolyngbya sp.Journal of the American Chemical Society, 2008
- PI3K/AKT inhibition induces caspase-dependent apoptosis in HTLV-1-transformed cellsVirology, 2008
- Symplocamide A, a Potent Cytotoxin and Chymotrypsin Inhibitor from the Marine Cyanobacterium Symploca sp.Journal of Natural Products, 2007